IBRX
ImmunityBio, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
6.72USD+7.348%(+0.46)15,869,693
Pre-marketNov 18, 2026 9:29:30 AM EST
6.28USD+0.319%(+0.02)
After-hoursNov 18, 2026 4:56:30 PM EST
6.73USD+0.149%(+0.01)
IBRX Financials
In Q3 FY 2026 (ended ), ImmunityBio, Inc. Common Stock (IBRX) reported revenue of $48.84M, net income of −$184.55M, operating cash flow of −$75.33M, and assets of $609.39M (filed ).
Loading financial flows…